• Supernews is evolving and is in the  process of re-modelling. As a result, our news coverage will be intermittent. Please watch this space for exciting new changes. "CHANGE THE HEADLINES, AND YOU CHANGE SOUTH AFRICA." Welcome to Supernews, A Citizen-Generated News Network, and Super Stage, A Live Innovation Campus Platform

By Danielle


rate this article

paradigm shifter

comments0 comments
views43 views
Tick one or all of the boxes if you think this Supernews report is Newsworthy, a Paradigm Shifter and/or Skillful. Once the icons turn green, yellow or red, click RATE NOW. By rating and commenting, you'll help our Citizen Journalists climb the ranks and become eligible for Super Stuff. Check out our Scorecard page for more info on how the point system works. hide

share this article

Advanced malaria test to improve diagnosis in Africa

Award winning Australian healthcare company, Atomo Diagnostics, who recently launched the innovative all in one rapid HIV test AtomoRapid™ HIV, are set to introduce its malaria counterpart to the continent at the 6th MIM Pan-African Malaria Conference in Durban this month.

AtomoRapid™ Malaria, which is ideal for both professional and self-test applications, will enable quick and reliable diagnosis of malaria in the field. Rapid testing away from hospitals and clinics is recognised as an increasingly important weapon in the fight to bring infectious diseases under control in Africa. Figures from The Global Fund, state that of the 655 000 malaria deaths worldwide in 2010, over 90% of these occurred in Africa.

A large scale study in Sudan revealed major user errors when using complicated malaria test kits. Through Collaborative Commercialisation, Atomo has ensured that these common errors are reduced through the integration of blood collection and delivery features into the test cassette.

John Kelly, the CEO & Founder of Atomo Diagnostics said, “Malaria is as much of a threat to the wellbeing of Africans as HIV is, so we wanted to ensure that we were also able to utilise the next-generation AtomoRapid™ solution to aid in the fight against Malaria”.

There is a serious need in Africa for reliable, rapid diagnostic tests that are easy to use in-field, especially in remote settings. A resistance to artemisimin – a key component of drugs used to treat malaria – is on the increase due to ‘blanket’ treatment programmes if the patient is suspected of having malaria. AtomoRapid™ Malaria aims to alleviate this issue by providing the healthcare worker with an easy to use and reliable diagnostic test to help make the decision on the course of treatment for the patient.

AtomoRapid™ Malaria will be manufactured in South Africa with production taking place at a new ISO 13485 certified facility. This makes it not only the world’s most user friendly rapid Malaria test, but an African made test that can be exported to the benefit of the rest of the world.

“The Atomo team has been working hard towards making AtomoRapid™ HIV and AtomoRapid™ Malaria available to the market at a competitive price and the response we have received so far has been fantastic – we now look forward to collaborating with leading organisations to change the Rapid testing landscape,” says Kelly who will present the AtomoRapid™ Malaria at the 6th MIM Pan-Africa Malaria Conference.


About Malaria in South Africa:
Today, South Africa still has malaria related deaths: In January 2012 the number of cases reported: 2267 with 16 deaths and in February 2012 there were 968 cases reported with 10 deaths.

Figures from The Global Fund:
Malaria infection numbers worldwide – 216 million
Of 655 000 (2010) malaria deaths worldwide – 91% of those are in Africa
Malaria kills a child somewhere in the world every 30 seconds



pixelstats trackingpixel
This entry was posted in Health and tagged , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *